Nomura

BPCE issued final guidance on Thursday for its latest multi-tranche Samurai sale, giving investors plenty of choice with two senior and three subordinated tranches.

The Australian dollar market, a popular funding pool for SSAs, will require a pragmatic approach in terms of price expectations next year, said senior SSA bankers.

Drug manufacturer Alkem Laboratories has set the price range for its Rp13.5bn ($202m) IPO in India, with the offering set to launch on December 8.

Albaraka Turk Katilim Bankasi (Albaraka Turk) priced Turkey’s first Basel III compliant tier two sukuk deal in line with guidance on Monday.

Coopération Pharmaceutique Française, the French pharmaceuticals distributor known as Cooper, has bank meetings scheduled on Wednesday for more than €350m of new debt for its leveraged buyout by Charterhouse.

Logan Property Holdings Co raised HK$1.55bn ($200m) from a top-up placement on November 25, which was well received despite investors’ lack of familiarity with the company.

Swedbank bucked a trend of issuers turning to covered bonds for funding on Thursday when it launched a five year fixed rate senior deal.

Logan Property Holdings Co raised HK$1.55bn ($200m) from a top-up placement on November 25, pulling off a successful trade despite the huge chunk of shares on sale and investors’ lack of familiarity with the company.

A careful build up helped Veneto Banca raise €200m in tier two debt on Tuesday, as the bank looks to improve its capital position ahead of a share sale in 2016.

Albaraka Turk Katilim Bankasi (Albaraka Turk) priced Turkey’s first Basel III compliant tier two sukuk deal in line with guidance on Monday.

Coopération Pharmaceutique Française, the French pharmaceuticals distributor known as Cooper, has bank meetings scheduled on Wednesday for more than €350m of new debt for its leveraged buyout by Charterhouse.

Royal Bank of Scotland has hired a well known high yield specialist to head corporate and event driven credit trading.